Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D5VMP4
|
|||
Drug Name |
BTX-A51
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Advanced solid tumour [ICD-11: 2A00-2F9Z; ICD-10: D10-D36, D3A] | Phase 1 | [1] | |
Non-hodgkin lymphoma [ICD-11: 2B33.5] | Phase 1 | [1] | ||
Company |
BioTheryX
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04872166) A Study of BTX-A51 in People With Advanced Solid Tumor or Non-Hodgkin Lymphoma. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of BioTheryX. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.